Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Subhamoy Chakraborty
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University,
Icahn School of Medicine at Mount Sinai
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
Tisch Cancer Institute,
The Ohio State University,
Icahn School of Medicine at Mount Sinai
ORCID:
0000-0003-0626-9011
Observed ORCID:
0000-0003-0626-9011
OpenAlex ID:
A5103019948
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
2024
·
Hirokazu Taniguchi
, Subhamoy Chakraborty
, et al.
·
Science Advances
·
61
De Novo and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
2023
·
Subhamoy Chakraborty
, Charles Coleman
, et al.
·
Clinical Cancer Research
·
26
PDF
Targeting NHEJ activates STING signaling through MYC degradation to boost antitumor immunity in SCLC
2026
·
Subhamoy Chakraborty
, Andrew Elliott
, et al.
·
Nature Communications
·
3
PDF
Protocol to co-culture SCLC cells with human CD8+ T cells to measure tumor cell killing and T cell activation
2025
·
Subhamoy Chakraborty
, Subhasree Sridhar
, et al.
·
STAR Protocols
·
2
Abstract 6554: Lurbinectedin induces multimodal immune activation and augments the anti-tumor immune response in small-cell lung cancer
2024
·
Subhamoy Chakraborty
, Yazhini Mahendravarman
, et al.
·
Cancer Research
·
2
Unveiling drivers of MHC repression and therapeutic strategies to counter immune evasion in small cell lung cancer.
2025
·
Triparna Sen
, Subhamoy Chakraborty
, et al.
·
Journal of Clinical Oncology
·
1
Subtype-Agnostic Biomarkers of Immunotherapy Response in Lung Cancer
2026
·
Elisa Gobbini
, Subhamoy Chakraborty
, et al.
·
Cancer Immunology Research
Figure 2 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Table S9 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Table S8 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Figure S2 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Table S3 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Figure S5 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Figure S6 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Data from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Table S7 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Figure S4 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Figure 3 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Table S5 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Figure S1 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Figure S3 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Table S1 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Supplementary Table S4 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Figure 4 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Figure 5 from Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
2026
·
Utsav Sen
, Dalia Natour
, et al.
Show more works
View as search
Works count:
68
Citation count:
95
H-index:
3
I10-index:
2
Year
Topic
Type